What Makes AnaptysBio, Inc. (ANAB) a New Buy Stock
https://www.zacks.com/stock/news/2240910/what-makes-anaptysbio-inc-anab-a-new-buy-stock?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_12_zacks_rank_upgrade-2240910
Mar 14, 2024 - AnaptysBio, Inc. (ANAB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
0
AnaptysBio, Inc. (ANAB) Reports Q4 Loss, Tops Revenue Estimates
https://www.zacks.com/stock/news/2238869/anaptysbio-inc-anab-reports-q4-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2238869
Mar 11, 2024 - AnaptysBio, Inc. (ANAB) delivered earnings and revenue surprises of 8.62% and 174.29%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
0
Analysts Estimate Lexicon Pharmaceuticals (LXRX) to Report a Decline in Earnings: What to Look Out for
https://www.zacks.com/stock/news/2233958/analysts-estimate-lexicon-pharmaceuticals-lxrx-to-report-a-decline-in-earnings-what-to-look-out-for?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_9-2233958
Feb 29, 2024 - Lexicon (LXRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
0
AnaptysBio, Inc. (ANAB) Expected to Beat Earnings Estimates: Should You Buy?
https://www.zacks.com/stock/news/2233279/anaptysbio-inc-anab-expected-to-beat-earnings-estimates-should-you-buy?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_9-2233279
Feb 28, 2024 - AnaptysBio, Inc. (ANAB) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
0
Strength Seen in AnaptysBio, Inc. (ANAB): Can Its 5.9% Jump Turn into More Strength?
https://www.zacks.com/stock/news/2227661/strength-seen-in-anaptysbio-inc-anab-can-its-5-9-jump-turn-into-more-strength?cid=CS-ZC-FT-tale_of_the_tape|daily_price_change_5%-2227661
Feb 19, 2024 - AnaptysBio, Inc. (ANAB) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
0
Corcept (CORT) Stock Rises on Upbeat Revenue Guidance for 2024
https://www.zacks.com/stock/news/2207538/corcept-cort-stock-rises-on-upbeat-revenue-guidance-for-2024?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2207538
Jan 09, 2024 - Corcept (CORT) issues encouraging preliminary results for the fourth quarter and full-year 2023. Shares of the company rise on robust 2024 revenue guidance.
0
Are Medical Stocks Lagging Acadia Healthcare (ACHC) This Year?
https://www.zacks.com/stock/news/2206965/are-medical-stocks-lagging-acadia-healthcare-achc-this-year?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_1-2206965
Jan 08, 2024 - Here is how Acadia Healthcare (ACHC) and AnaptysBio, Inc. (ANAB) have performed compared to their sector so far this year.
0
Pages: 1
Page 1